Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat
Open Access
- 13 September 2006
- journal article
- research article
- Published by Springer Nature in BMC Women's Health
- Vol. 6 (1) , 14
Abstract
Tamoxifen, a selective estrogen receptor modulator with both estrogenic and anti-estrogenic activity, is widely used as adjuvant therapy in breast cancer patients. Treatment with tamoxifen is associated with sexual side effects, such as increased vaginal dryness and pain/discomfort during sexual activity. There have been limited investigations of the effect of tamoxifen on estrogen-dependent peripheral genital arousal responses. The objective of this study was to investigate the effects of tamoxifen on vaginal physiology in the rat. Female Sprague-Dawley rats were subjected to sham surgery or bilateral ovariectomy. After 2 weeks, sham-operated rats were implanted with subcutaneous osmotic infusion pumps containing vehicle (control) or tamoxifen (150 μg/day). Ovariectomized rats were similarly infused with vehicle. After an additional 2 weeks, vaginal blood flow responses to pelvic nerve stimulation were measured by laser Doppler flowmetry and vaginal tissue was collected for histological and biochemical assay. Tamoxifen treatment did not change plasma estradiol concentrations relative to control animals, while ovariectomized rats exhibited a 60% decrease in plasma estradiol. Tamoxifen treatment caused a significant decrease in mean uterine weight, but did not alter mean vaginal weight. Vaginal blood flow was significantly decreased in tamoxifen-infused rats compared to controls. Similar to ovariectomized animals, estrogen receptor binding was increased and arginase enzyme activity was decreased in tamoxifen-infused rats. However, different from control and ovariectomized animals, the vaginal epithelium in tamoxifen-infused rats appeared highly mucified. Periodic acid-Schiff staining confirmed a greater production of carbohydrate-rich compounds (e.g. mucin, glycogen) by the vaginal epithelium of tamoxifen-infused rats. The observations suggest that tamoxifen exerts both anti-estrogenic and pro-estrogenic effects in the vagina. These physiological alterations may eventually lead to vaginal atrophy and compromise sexual function.Keywords
This publication has 61 references indexed in Scilit:
- Effect of anti-estrogens on the androgen receptor activity and cell proliferation in prostate cancer cellsUrological Research, 2004
- An In Vivo Rat Model to Investigate Female Vaginal Arousal ResponseJournal of Urology, 2004
- Effects of ovariectomy and steroid hormones on vaginal smooth muscle contractilityInternational Journal Of Impotence Research, 2004
- Sex steroid hormones differentially regulate nitric oxide synthase and arginase activities in the proximal and distal rabbit vaginaInternational Journal Of Impotence Research, 2003
- Tamoxifen: a most unlikely pioneering medicineNature Reviews Drug Discovery, 2003
- Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapyBritish Journal of Cancer, 2002
- Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal womenBritish Journal of Cancer, 2001
- Decreased circulating levels of estrogen alter vaginal and clitoral blood flow and structure in the rabbitInternational Journal Of Impotence Research, 2001
- Tamoxifen binding sites heterogeneity in breast cancer: a comparative study with steroid hormone receptorsEuropean Journal of Cancer and Clinical Oncology, 1991
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984